Morphic Therapeutic, Inc. (a Wholly Owned Subsidiary Of Eli Lilly And Company)

This study tests three different doses of an experimental drug called MORF-057 in 280 adults with moderate to severe ulcerative colitis, a chronic inflammatory bowel disease. The goal is to see if the drug can safely help patients achieve remission, meaning less bleeding, more no…